Role of Nuclear Medicine In Management of Relapsing Lymphoma
Maha Abd-Elkareem Elsayed;
Abstract
The use of unlabelled immunotherapy (rituximab) in treatment of relapsed NHL proven by many studies done a high efficiency rate with a relatively fewer side effects compared to other conventional therapeutic modalities. Thus rituximab therapy has substant
Other data
| Title | Role of Nuclear Medicine In Management of Relapsing Lymphoma | Authors | Maha Abd-Elkareem Elsayed | Keywords | Role of Nuclear Medicine In Management of Relapsing Lymphoma | Issue Date | 2008 | Description | The use of unlabelled immunotherapy (rituximab) in treatment of relapsed NHL proven by many studies done a high efficiency rate with a relatively fewer side effects compared to other conventional therapeutic modalities. Thus rituximab therapy has substant |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 15673Dr. Maha Abd-Elkareem Elsayed.pdf | 184.19 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.